The announcement of the new test comes as the U.S. has failed to substantially increase its capacity to test for Covid-19 broadly throughout the population.
The Food and Drug Administration has issued an emergency use authorization for a new coronavirus test from Quest Diagnostics that allows people to collect their sample from home, the company announced Thursday.Quest's new test is not the first to allow people to collect their own samples at home and ship it in to a lab.
A medical provider bags a completed test at the STRIDE Community Health Center's COVID-19 drive-thru testing site at the Aurora Health and Wellness Plaza March 26, 2020.The Food and Drug Administration has issued an emergency use authorization for a new coronavirus test fromthat allows people to collect their sample from home, the company announced Thursday.
The company said it will make more than 500,000 of the kits available by the end of next month. The self-collection kit will include a swab that allows people to collect a sample from their nostril and can then be shipped overnight with"COVID-19 molecular diagnostic testing has been constrained partly by limited supplies of swabs and trained healthcare professionals to do the specimen collection," Quest CEO Steve Rusckowski said in a statement.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Coronavirus live updates: Brazil outbreak threatens Bolsonaro; vaccine a '2021 event,' former FDA chief says“There’s no amount of money that Congress can come up with, even in the trillions, that can replace what we need to do in terms of opening this economy,” former House Majority Leader Eric Cantor says.
Read more »
FDA Loosens Labeling Rules for Ingredient Substitutions Due to CoronavirusThe temporary change is intended to provide flexibility due to supply chain disruptions—does it mean we won't know exactly what’s in our food?
Read more »
Medical Groups Ask FDA To Ease Access To Abortion Pill During The PandemicReproductive rights advocates are suing the Trump administration, asking a federal court to allow patients to receive the abortion drug mifepristone by mail during the pandemic — instead of only at a hospital or medical facility.
Read more »
FDA Temporarily Allows Minor Ingredient Changes Without Label Disclosures Amid PandemicAdvocacy groups are concerned that the FDA's temporary policy allowing minor ingredient changes without label disclosures will become permanent amid a pattern of deregulation
Read more »
LA Sues California Company, Alleging 'Sophisticated' COVID-19 FraudThe city attorney accuses Wellness Matrix Group of 'shocking deceptive conduct' over its sales of purported 'at-home' coronavirus tests and virus-killing disinfectant.
Read more »
O.C. company profited off fake coronavirus tests, prosecutors sayA Huntington Beach company falsely promised buyers an FDA-approved coronavirus home testing kit with results in 10 minutes, L.A. city attorney says.
Read more »